Viewing nowCombinationExcombi 5/160 mg
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201308574 · Approved 2013.07.31 · Insurance code 671805570
Treatment of essential hypertension not adequately controlled with monotherapy
This medicine is used for patients with essential hypertension where blood pressure is not sufficiently controlled by amlodipine or valsartan alone. The two drugs work together to effectively lower blood pressure, helping to manage hypertension. This reduces the risk of cardiovascular complications and improves overall health. Therefore, this medicine is effective for blood pressure control.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before this medicine is administered. However, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be stopped immediately if pregnancy is confirmed. This medication should not be used in individuals who are allergic to the active ingredients or similar drugs, women who are pregnant or breastfeeding, and patients with severe kidney or liver diseases. Patients who are low in sodium or fluids may experience low blood pressure, so their condition should be checked before administration, and if symptoms of low blood pressure occur, they should lie down and rest immediately. Patients with high potassium levels must be cautious when taking this drug and potassium supplements or medications that may increase potassium, and should have their serum potassium levels frequently monitored. Patients with vascular issues in the kidneys or those who have received a kidney transplant require close monitoring as this medication may affect kidney function. If symptoms of angioedema (swelling of the face, lips, tongue, etc.) occur during treatment, discontinue the medication immediately and do not resume. Patients with heart failure or following myocardial infarction should be observed closely for any changes in kidney function while taking this medication, and patients with acute myocardial infarction should be careful as angina or myocardial infarction may worsen during treatment with this drug. The dose for patients with weak liver function should be limited, and it should not be used in patients with severe liver disease. Caution is advised as dizziness or fatigue may occur when driving or operating machinery. This medication may interact with other antihypertensives, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so it is essential to inform your doctor or pharmacist if there are any other medications being taken. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid it. This medication is not recommended for patients under 18 years of age as its safety and efficacy have not been established. In the elderly, it can be administered at doses similar to those for general adults, but their condition should be carefully monitored. In case of overdose, low blood pressure, dizziness, and in severe cases, shock may occur, so immediate medical attention is required.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, urinary frequency, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurogenic sensitivity, sensory impairment, Stevens-Johnson syndrome, dizziness, fatigue, rapid blood pressure drop, hypotension, syncope, loss of consciousness, symptomatic hypotension, increased blood urea, increased serum creatinine, increased BUN, pulmonary edema, decreased urine output, progressive azotemia, acute renal failure, death, angina, acute myocardial infarction, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea, non-cardiogenic pulmonary edema, reflex tachycardia, systemic hypotension, shock
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and should be kept at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication.
Dark yellow oval film-coated tablets
Domestic: 30 tablets (10 tablets/PTP X 3), Export: 30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.